Afinion™ 2 analyzer test system

Abbott has announced the availability of a new diabetes testing system, which can give providers results in just minutes.

The Afinion 2 analyzer is compact and rapid, able to accurately measure patient’s hemoglobin A1c levels in just three minutes, and albumin to creatinine ratios in just five. The new technology is ideal for use in long-term care facilities and other outpatient settings, according to a statement from the Abbott Park, IL, company.

“By delivering rapid HbA1c and ACR test results, the Afinion 2 analyzer does more than streamline care; its life-changing technology helps people living with diabetes get the most out of their healthcare visits,” said Elizabeth Balthrop, Abbott’s divisional vice president of Cardiometabolic and Informatics. “Within a single visit, patients can obtain real-time feedback and insights on their condition, have an informed discussion with their provider and leave with a defined care plan.”